isoproterenol and vitexin

isoproterenol has been researched along with vitexin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, ZM; Hang, PZ; Lu, CC; Qi, JC; Wang, C; Wang, Y; Wu, JC; Wu, JW; Xu, YQ; Zhang, Y1
Ashokkumar, R; Jamuna, S; Niranjali Devaraj, S; Sakeena Sadullah, MS1

Other Studies

2 other study(ies) available for isoproterenol and vitexin

ArticleYear
Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:8

    Topics: Animals; Animals, Newborn; Apigenin; Calcineurin; Calcineurin Inhibitors; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Isoproterenol; Male; Mice; Myocytes, Cardiac; Pressure; Rats; Rats, Wistar; Signal Transduction

2013
Vitexin protects isoproterenol induced post myocardial injury by modulating hipposignaling and ER stress responses.
    Biochemical and biophysical research communications, 2018, 02-05, Volume: 496, Issue:2

    Topics: Animals; Antioxidants; Apigenin; Apoptosis; Cardiotonic Agents; Caspase 3; Endoplasmic Reticulum Stress; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Signal Transduction

2018